Menu
Washingtoner
  • Home
  • Boeing
  • Aerospace
  • Technology
  • Daryl Guberman
  • Health
  • Financial
  • Business
  • ANSI-ANAB
Washingtoner

Tasso Announces Launch of Tasso Care® for Prescreening
Washingtoner/10247375

Trending...
  • City Council to Discuss 'Connect Tacoma' Transportation Levy Replacement at April 14 Study Session
  • Acuvance Appoints Sandeep Sabharwal to Board of Directors, Strengthening Leadership to Support Continued Platform Growth
  • iVAM2-ST2110 to Simplify IP Transitions and Reduce Monitoring Complexity
SEATTLE ~ Seattle, WA - Tasso, Inc., a leading provider of patient-centric blood collection solutions, has announced the launch of their new service, Tasso Care® for Prescreening. This end-to-end solution aims to improve the success of prescreening programs by expanding on the company's expertise in remote blood collection and analysis.

Tasso Care for Prescreening is specifically designed to support the prescreening of participants in clinical trials for various cardiometabolic and serostatus markers. The company plans to add additional panels for immunology, cardiovascular disease, and other therapeutic areas throughout the first quarter of 2024 as validation protocols are completed.

According to Tasso CEO and Co-Founder Ben Casavant, PhD, screening participants is a major bottleneck in drug development that often leads to trial delays and high screen failure rates. With Tasso Care, this process is revolutionized by replacing time-consuming clinic visits with convenient and automated prescreening testing at scale.

More on Washingtoner
  • Tacoma: Street Closure Projected to Start the Week of April 20 for Residential Street Restoration Program Maintenance Work
  • Colorfront Launches New Mac App For Creating Apple Immersive Video
  • Michele Mundy's "Divinely Tailored" Gains Momentum
  • Evermore Bliss Launches AI Wedding Speech Writer to Help Users Create Personalized, Heartfelt Toasts
  • Keenethics enters the ChatGPT Apps ecosystem as a new growth opportunity for businesses

By offering a virtually painless blood draw experience from the comfort of home, Tasso aims to increase clinical trial engagement rates by simplifying the operational process and optimizing the participants' experience. This also ensures a high-quality sample is returned to the lab. Additionally, Tasso Care allows for large populations to be screened simultaneously anytime and anywhere, ultimately increasing trial access and diversity.

Casavant believes that accelerating and expanding access to clinical trials is crucial in improving healthcare. He states that trials often face enrollment delays due to difficulties in identifying rare populations and obtaining up-to-date data. With Tasso Care for Prescreening, these challenges can be overcome as screening becomes more scalable and convenient.

It should be noted that Tasso Care for Prescreening is intended for use under institutional review board (IRB)-reviewed prescreening protocols. To learn more about this new service from Tasso Inc., please visit their website at www.tassoinc.com/prescreening.
Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • Dual-Engine Growth Strategy Unleashed Targeting a $9.1B Market and the Exploding AI Biotech Revolution: KALA BIO (N A S D A Q: KALA)
  • GitKraken Desktop 12.0 Introduces Agent Mode: Gives Developers Ultimate Control & Visualization While Scaling Parallel Agent Workflows
  • 5 Things to Check Before Calling for AC Repair in Philly
  • Go Dental Clinic Announces Upcoming Opening of New Branch in International City, Dubai
  • Hazel E Hosts Starline Tours Bus to Sonic Desert - A Launch to Coachella
  • City Seeks Community Members Interested in Preparing Statements 'For' and 'Against' Proposition 1, the 'Connect Tacoma: Safe Streets and Sidewalks' Ballot Measure
  • Contracting Resources Group and Aalis Management Consulting Launch ARG Joint Venture Under SBA Mentor-Protégé Program
  • Card makers turn to Pink and Main for tools to support their craft
  • Revenue Optics Completes Full Commercial Buildout. A Nine-Month-Old Firm Built on 25 Years of Distribution Expertise. Five Clients From $200M to $3B
  • EduCare Inc. Bridges Critical Gap in Breast Cancer Education with Spanish COPE Library Launch
  • Engineering leaders from industry, academia to gather at IISE Annual Conference & Expo in Arlington, Texas
  • AI-Driven Neurotechnology Expansion as FDA Path Clears and New Defense Initiative Emerges for NRx Pharmaceuticals (N A S D A Q: NRXP)
  • BestDoc Launches AI Call Center for Healthcare
  • Acuvance Appoints Sandeep Sabharwal to Board of Directors, Strengthening Leadership to Support Continued Platform Growth
  • Grange Insurance Association to Rebrand as Granwest Insurance on July 1, 2026
  • Dr. Rosendo Icochea, MD Recognized for Contributions to Surgical Education and Medical Research
  • Giftella Launches AI Gift-Finder App That Replaces Guesswork With Personalized Picks in Seconds
  • Beverly.io Announces Nationwide Expansion and Poppins Payroll Partnership for Families
  • City Council Adopts Resolution Transmitting 'Connect Tacoma' Ballot Measure to Pierce County Auditor for August 4, 2026 Primary Election Ballot
  • Lucky Envelope Brewing Celebrates 11th Anniversary
_catLbl0 _catLbl1

Popular on Washingtoner

  • Registered Nurse Launches Healthcare Wealth Strategy Practice for Healthcare Professionals - 610
  • A Letter From the Tacoma City Council to the Sound Transit Board
  • Foiling Freaks Launches New Online Platform Dedicated to Foiling Board Sports
  • Mensa Brings National Board Game Competition to Northern Virginia April 16-19
  • Monexplora Explains the Options Mechanics Behind March's Tech Selloff and VIX Surge
  • Tacoma: Lincoln Avenue Bridge to Close Saturday, April 18 for Asphalt Repairs
  • KeysCaribbean Offers 'Skip-the-Crowds' Savings With 15 Percent Off April Stays
  • City Council to Discuss ‘Connect Tacoma’ Transportation Levy Replacement at April 14 Study Session
  • Spokane: Call for High School Artists: 2026 Riverfront Park Poster Contest
  • Attorney Joseph C. Kreps Files Lawsuit to Stop Alabama State Board of Pharmacy's Unlawful "Revenue-First" Rulemaking

Similar on Washingtoner

  • Creator Space LA brings together industry leaders for an immersive AI showcase, demonstrations, and film hackathon
  • Uxur Taxi Unveils Luxury 3,000‑Mile Private Driver Service for Nationwide Travel
  • UK Financial Ltd Launches UKFL Premier One as Its Official Broadcast Channel for Premium Content, Podcasts & Independent Expert Analysis
  • Dual-Engine Growth Strategy Unleashed Targeting a $9.1B Market and the Exploding AI Biotech Revolution: KALA BIO (N A S D A Q: KALA)
  • Revenue Optics Completes Full Commercial Buildout. A Nine-Month-Old Firm Built on 25 Years of Distribution Expertise. Five Clients From $200M to $3B
  • AI-Driven Neurotechnology Expansion as FDA Path Clears and New Defense Initiative Emerges for NRx Pharmaceuticals (N A S D A Q: NRXP)
  • BestDoc Launches AI Call Center for Healthcare
  • Acuvance Appoints Sandeep Sabharwal to Board of Directors, Strengthening Leadership to Support Continued Platform Growth
  • $7.6 Billion US Crypto ATM Market by 2034; California and Texas Crypto ATM Deployments for Bitcoin Bancorp (Stock Symbol: BCBC); 1000 Kiosk Inventory
  • iVAM2-ST2110 to Simplify IP Transitions and Reduce Monitoring Complexity
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute